These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21400969)

  • 1. Expectations for tPA is pathway to litigation.
    ED Manag; 2011 Feb; 23(2):18-9. PubMed ID: 21400969
    [No Abstract]   [Full Text] [Related]  

  • 2. Litigation regarding tPA and stroke.
    Pilcher CA
    Ann Emerg Med; 2009 Mar; 53(3):404; author reply 404-5. PubMed ID: 19231673
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
    Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
    J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a stroke alert protocol in the emergency department: a pilot study.
    Hoegerl C; Goldstein FJ; Sartorius J
    J Am Osteopath Assoc; 2011 Jan; 111(1):21-7. PubMed ID: 21258013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroking the data: re-analysis of the NINDS trial.
    Magid D; Naviaux N; Wears RL
    Ann Emerg Med; 2005 Apr; 45(4):385-7. PubMed ID: 15795716
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA; Lew R; Zivin JA
    Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical characteristics of litigation involving tissue plasminogen activator and ischemic stroke.
    Liang BA; Zivin JA
    Ann Emerg Med; 2008 Aug; 52(2):160-4. PubMed ID: 18313798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 9. A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments.
    Switzer JA; Hall C; Gross H; Waller J; Nichols FT; Wang S; Adams RJ; Hess DC
    J Emerg Med; 2009 Jan; 36(1):12-8. PubMed ID: 18242925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
    Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
    Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department.
    ; Brown MD; Burton JH; Nazarian DJ; Promes SB
    Ann Emerg Med; 2015 Sep; 66(3):322-333.e31. PubMed ID: 26304253
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 13. Using tPA for acute stroke in a rural setting.
    Gross H; Hall C; Switzer JA; Adams RJ; Wang S; Hess DC; Nichols FT; Pardue C
    Neurology; 2007 May; 68(22):1957-8; author reply 1958. PubMed ID: 17536059
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
    Hoffman JR
    Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue plasminogen activator (tPA) in acute ischaemic stroke: time for collegiate communication and consensus.
    Levi CR; ; ;
    Med J Aust; 2004 Jun; 180(12):634-6. PubMed ID: 15200362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right brain: my first tPA.
    Robbins MS
    Neurology; 2009 Jul; 73(2):e9-e10. PubMed ID: 19597130
    [No Abstract]   [Full Text] [Related]  

  • 17. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Walsh M; Fromm G
    Ann Emerg Med; 2006 Mar; 47(3):297. PubMed ID: 16492504
    [No Abstract]   [Full Text] [Related]  

  • 18. Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing.
    Wang Y; Wu D; Zhao X; Ma R; Guo X; Wang C; Liu L; Zhao W; Wang Y
    Surg Neurol; 2009 Aug; 72 Suppl 1():S2-7. PubMed ID: 18423545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of MRI in the identification and treatment of early ischemic stroke lesions.
    O'Rourke F; Akhtar N; Emery D; Shuaib A
    CMAJ; 2004 Feb; 170(3):335-6. PubMed ID: 14757667
    [No Abstract]   [Full Text] [Related]  

  • 20. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
    Fink J
    N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.